FEBNM

Certificate of Fellowship of the European Board of Nuclear Medicine

Neuroendocrine Tumour TheranosticsEnglish
Exam overview

Practice session

A patient with metastatic well-differentiated ileal neuroendocrine tumour is considered for peptide receptor radionuclide therapy. Which imaging pattern most strongly supports suitability for lutetium-177 DOTATATE therapy?

Loading your practice session…